Latest ArticlesTo investigate the effects of erianin on renal fibrosis in diabetic nephropathy (DN) rats and its regulatory mechanism.
All male SD rats were divided into control group, model group, dexamethasone group, vertepofin group, low-dose erianin group, high-dose erianin group and erianin combined with dexamethasone group, with 10 rats in each group. The levels of microalbuminuria (MAU) and renal function were detected. The renal tissue pathological changes and collagen fibers deposition were observed. The levels of malondialdehyde (MDA) and superoxide dismutase (SOD) in renal tissue were detected. Real-time quantitative polymerase chain reaction was used to detect tumor necrosis factor (TNF)-α, interleukin (IL)-1β and transforming growth factor (TGF)-β1 mRNA level. Western blotting was used to detect the Yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TZA), connective tissue growth factor (CTGF), fibronectin (FN), and plasminogen activator inhibitor-1 (PAI-1) protein expression.
Compared with the control group, MAU, serum creatinine (Scr), blood urea nitrogen (BUN), propylene diol content, messenger (m) RNA levels of TNF-α, IL-1β, TGF-β1 and protein expression of YAP, TAZ, CTGF, FN, PAI-1 in model group and dexamethasone group were increased, while SOD activity was decreased (P<0.05). Compared with model group, MAU, Scr, BUN, propanediol content, mRNA levels of TNF-α, IL-1β, TGF-β1 and protein expression of YAP, TAZ, CTGF, FN and PAI-1 in vertepofin group and erianin group were decreased, while SOD activity was increased (P<0.05). After dexamethasone was added in the supplement experiment, the protective effect of high dose of erianin on DN rats was reversed (P<0.05).
Erianin can alleviate renal fibrosis in DN rats by inhibiting YAP/TAZ signaling pathway.
To investigate the therapeutic effect of compound Shougong power combined with zoledronic acid on bone metastasis of lung cancer, and the effect on B lymphocyte induced maturation protein (Blimp)1/B cell lymphoma factor (Bcl)-6 pathway.
The mouse model of lung cancer bone metastasis was established and divided into bone metastasis group, low dose of traditional Chinese medicine (40 mg/kg compound Shougong powder) group, high dose of traditional Chinese medicine (120 mg/kg compound Shougong powder) group, western medicine (50 μg/kg zoledronic acid) group and combined treatment (120 mg/kg compound Shougong powder+50 μg/kg zoledronic acid) group, and set up sham operation group, with 10 mice in each group. After 21 days, tibial injury, pathological morphology, number of osteoclasts, in vivo imaging system fluorescence signal of bone metastasis and expression levels of Blimp1 and Bcl6 in tibial tissue were observed.
Compared with the sham operation group, the number of osteoclasts, tumor cell fluorescence signals and Blimp1 expression in bone metastasis group were increased, while the Bcl-6 expression decreased (P<0.01). Compared with the bone metastasis group, the number of osteoclasts, tumor cell fluorescence signal and Blinp1 expression in the low and high dose traditional Chinese medicine groups and the western medicine group decreased, while Bcl-6 expression increased (P<0.01). Combination therapy enhanced the therapeutic effect of bone metastasis in lung cancer (P<0.01).
The combination of compound Shougong powder and zoledronic acid has a synergistic effect in the treatment of lung cancer bone metastasis, which may be related to the inhibition of the Blinmp1/Bcl-6 pathway.
To investigate the effects of cisatracurium on proliferation and apoptosis of human osteosarcoma cell Saos-2 and its possible mechanism.
Saos-2 cells were cultured in vitro and randomly divided into control group, cisatracurium low, medium and high dose groups. Real time quantitative polymerase chain reaction was used to detect the expression of micro RNA (miR)-505. MTT, plate clone formation experiment and flow cytometry were used to detect cell proliferation, clone formation and apoptosis, respectively.
Compared with the control group, the cell proliferation inhibition rate, apoptosis rate and miR-505 expression were increased in cisatracurium low, medium and high dose groups, and the number of clone formation was decreased in a dose-dependent manner (P<0.05). After transfection of miR-505 mimics, the cell proliferation inhibition rate and apoptosis rate increased, and the number of clone formation was decreased (P<0.05). After transfection of miR-505 inhibitor combined with cisatracurium, the cell proliferation inhibition rate and apoptosis rate decreased, and the number of clone formation was increased (P<0.05).
Cisatracurium can inhibit the proliferation and cloning of Saos-2 cells and promote apoptosis by up-regulating the expression of miR-505.
To investigate the effects of Stanozolol on amino acid neurotransmitters and growth hormone (GH)/insulin-like growth factor-1 (IGF-1) in growth hormone deficiency mice.
Fifty-four mice were randomly divided into healthy group (group A), model group (group B), low-dose Stanozolol group (group C), medium-dose Stanozolol group (group D), high-dose Stanozolol group (group E), and prednisone acetate group (group F), with 9 mice in each group. During the administration period, body weight gain of mice was calculated. The levels of amino acid neurotransmitters glutamic acid (Glu) and γ-aminobutyric acid (GABA) in serum, as well as GH levels were determined by enzyme-linked immunosorbent assay. Hematoxylin-eosin staining was used to observe the histomorphology of tibia. Immunoblotting and polymerase chain reaction were used to detect the expressions of IGF-1 and GH in hippocampus tissue.
Compared with group A, rats in group B had decreased body weight, serum GABA and GH levels, and IGF-1, GH mRNA, and protein expression levels in hippocampus tissue, while serum Glu level was increased (P<0.01). Compared with group B, rats in group C had increased body weight, serum GABA and GH levels, and IGF-1 and GH expressions in hippocampus tissue, while serum Glu level was decreased (P<0.01). Compared with group C, rats in group D had increased body weight, serum GABA and GH levels, and IGF-1 and GH expressions in hippocampus tissue, while serum Glu level was decreased (P<0.01). Compared with group D, rats in group E had increased body weight, serum GABA and GH levels, and IGF-1 and GH expressions in hippocampus tissue, while serum Glu level was decreased (P<0.01). There were no differences in body weight, serum GABA, Glu, GH, and IGF-1 and GH expressions in hippocampus tissue between group E and group F (P>0.05).
Stazolol can regulate amino acid neurotransmitters in GHD mice, down-regulate Glu content, increase GABA content and promote the expression of endocrine GH/IGF-1 signaling pathway, which provides a new idea for GHD treatment.
To observe the effects of baritinib on haemoglobin (Hb) levels in patients with rheumatoid arthritis (RA) with moderate to high disease activity.
RA patients receiving biologics or targeted synthetic drugs admitted to the Department of Arthropathy of Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine from September 2021 to May 2023 were retrospectively included. During the study, 60 patients were enrolled in the baritinib group, and the tumor necrosis factor inhibitor (TNFi) group was matched by random selection at the ratio of 1:1, so 60 patients in each group. The clinical information of all patients at baseline and 12-week follow-up period were collected, and the changes of Hb levels were monitored.
After treatment, 42 patients in TNFi group and 45 patients in baritinib group reached the therapeutic effect standard, and there was no statistical significance between the two groups (P>0.05). After 12 weeks of treatment, Hb level in bariatinib group was higher than that before treatment, and there was no significant difference between responders and non-responders (P>0.05). After treatment, Hb level in patients with anemia at baseline increased by 8.21 g/L, while that in those without anemia increased by 0.66 g/L, with statistical significance (P<0.05).
The efficacy of baritinib in the treatment of moderate to high disease activity RA is comparable to that of TNFi. Baritinib can improve anemia in RA patients by reducing inflammation, and Hb levels in patients with baseline anemia increased significantly after 12 weeks of treatment, and the extent of increase was significantly higher than that in patients without baseline anemia.
To investigate the effects of Xuesuisheng granule combined with cyclosporine (Cs) A on non-severe aplastic anemia (NSAA) and its effects on GATA binding protein (GATA)-3, granulocyte colony stimulating factor (G-CSF) and early hematopoietic recovery.
Forty-six patients with NSAA admitted to our hospital from June 2021 to January 2023 were selected and divided into observation group (n=24) and control group (n=22) by random number table. The control group was treated with CsA, and the observation group was treated with Xuesuisheng granules. The clinical efficacy, changes in GATA-3, G-CSF, hemoglobin (Hb), red blood cells (RBC), hematocrit (HCT), cellular immune function and the occurrence of adverse reactions were compared between the two groups.
The total effective rate of the observation group was higher than that of the control group, but the difference was not statistically significant (54.55% vs 75.00%, P>0.05). Compared with the control group, the levels of GATA-3, cluster of differentiation CD4+ and CD4+/CD8+ in the observation group were decreased (P<0.05), while the levels of G-CSF, Hb, RBC, HCT and CD8+ were increased (P<0.05). The adverse reactions in the observation group were less than those in the control group, but the difference was not statistically significant (36.36% vs 25.00%, P>0.05).
Xuesuisheng granule combined with CsA can improve GATA-3, G-CSF and early hematopoiesis in patients with NSAA to a certain extent.
To observe the efficacy and safety of Pudilan Xiaoyan oral liquid in the treatment of moderate acne vulgaris with dampness and heat.
A total of 210 cases of moderate acne vulgaris were collected according to the principles of multi-center, randomized, double-blind single simulation and placebo parallel control. Among them, 105 cases in the experimental group were treated with Pudilan anti-inflammatory oral liquid+clindamycin gel, the control group (105 patients) were treated with Pudilan Xiaoyan oral liquid simulator+clindamycin gel for 4 weeks. The clinical efficacy was evaluated after the treatment.
The effective rate of the experimental group was 86.54%, and the recovery rate was 4.81%, while the effective rate of the control group was 35.92%, and the recovery rate was 0.00%, and the difference was statistically significant (P<0.05). The total number of skin lesions and the improvement of papules and pustules in experimental group were significantly better than those in the control group, with statistical significance (P<0.05). The experimental group was better than the control group in improving the tongue coating and constipation, and the difference was statistically significant (P<0.05). In terms of safety, no adverse reactions were observed in the experimental group and the control group.
Pudilan Xiaoyan oral liquid in the treatment of moderate acne vulgaris of damp-heat type has obvious curative effect, quick effect and small adverse reaction.
To evaluate the clinical efficacy and safety of "medicine-bath-ointment" therapy in the treatment of blood heat syndrome of plaque psoriasis.
A total of 77 patients were randomly divided into experiment group (n=39) and control group (n=38). Both groups were given Niu 1 decoction, while the experiment group was treated with Xiaoyin No.1 decoction medicinal bath. The clinical efficacy and psoriasis area and severity index (PASI) of the two groups before and after treatment were observed, and the adverse reactions and recurrence rates were analyzed.
The total effective rate of treatment in the experimental group is higher than that in the control group (92.31% vs 78.94%, P<0.05). After treatment, the total PASI scores of both groups were lower than before treatment, and the infiltration and desquamation indices of the experimental group decreased, the differences were statistically significant (P<0.05). There was no statistically significant difference in recurrence rates between the two groups (7.69% vs 7.89%, P=0.923). There were no significant adverse reactions in the both groups.
"Medicine-bath-ointment" therapy has good clinical efficacy and safety in the treatment of plaque psoriasis with blood heat syndrome.
To establish an evaluation index system for the rational use of drugs in the treatment of multiple myeloma (MM).
A total of 30 experts were selected for two rounds of expert consultation by Delphi method. The opinions of experts were collected and the results were statistically analyzed. The basic information and questionnaire results of the questioned experts were analyzed, and the positive coefficient, average score, full score ratio, coefficient of variation and weight value were calculated.
The evaluation indexes of rational use of MM drugs included 6 primary indexes and 36 secondary indexes. The effective recovery rate of the expert questionnaire was 100%, the authority coefficient was 0.86, and the coordination coefficient was 0.293, which had statistical significance (P<0.001).
The experts are highly motivated, authoritative and coordinated, and the evaluation system of MM is objective and reasonable, which can provide quantifiable evaluation for MM drug selection.
To explore the clinical efficacy and safety of Yishen granule combined with warm acupuncture and moxibustion in the treatment of myelosuppression after chemotherapy of lung cancer.
A total of 66 lung cancer patients with post-chemotherapy myelosuppression admitted to the department of oncology, Yueyang Hospital of Integrated Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine from July 1, 2019 to August 31, 2022 were included and randomly divided into control group and experiment group, with 33 cases in each group. The control group was treated with Yishen granules orally, and the experiment group was treated with Yishen granules combined with warm acupuncture. The changes of bone marrow suppression indexes, including white blood cell count, neutrophil count, hemoglobin count and platelet count, were observed before treatment, 7 and 14 days after treatment. The European Organization for Research and Treatment of Cancer Quality of Life Scale was used to assess the quality of life of patients.
Compared with before treatment, myelosuppression indexes in both groups were significantly improved after 7 and 14 days of treatment, and the differences were statistically significant (P<0.05). After 14 days of treatment, the leukocyte count of the experiment group was significantly higher than that of the control group [(4.92±1.38)×109/L vs (4.13±1.62)×109/L, (P<0.05)]. The improvement of emotional function, total health status, fatigue and loss of appetite in experiment group was better than that in control group (P<0.05).
Yishen granule combined with warm acupuncture and moxibustion can effectively treat myelosuppression after chemotherapy for lung cancer, and the effect is slightly better than that of Yishen granule alone.